FMNL1 Activators encompass a range of chemical compounds that indirectly enhance the functional activity of FMNL1, a protein involved in actin polymerization and cytoskeletal reorganization. Key among these activators are compounds that influence actin dynamics, such as Jasplakinolide, Latrunculin A, Latrunculia magnifica, Cytochalasin D, and Phalloidin. Jasplakinolide, by stabilizing actin filaments, potentially increases the demand for FMNL1's activity in forming and organizing these filaments. In contrast, Latrunculin A and Cytochalasin D disrupt actin filament formation and elongation, respectively, potentially leading to a compensatory upregulation of FMNL1 activity in actin nucleation and branching. Phalloidin, another actin stabilizer, indirectly enhances FMNL1's role in actin dynamics by increasing the requirement for functional actin networks.
Other compounds modulate cellular signaling pathways, indirectly affecting FMNL1 activity. Forskolin, by increasing cAMP levels, can modulate signaling pathways governing cytoskeletal dynamics, potentially enhancing FMNL1 function. Inhibitors like CK 666, Y-27632, free base, ML-7 hydrochloride, and (S)-(-)-Blebbistatin, which target different aspects of the actin cytoskeleton and associated proteins, can shift cellular reliance on FMNL1 for maintaining cytoskeletal integrity. Wiskostatin, as an N-WASP inhibitor, also contributes to this modulation by altering the balance in actin polymerization dynamics. Collectively, these FMNL1 Activators, through their diverse effects on actin filament formation and cellular signaling, play a critical role in modulating the functions of FMNL1, highlighting the complex interplay of biochemical and cellular mechanisms in cytoskeletal organization and cellular morphology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can enhance FMNL1 activity by promoting its role in actin polymerization and cytoskeletal reorganization. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises cAMP levels, which can indirectly enhance FMNL1 activity by modulating signaling pathways that govern cytoskeletal dynamics and actin polymerization. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, free base, a ROCK inhibitor, can alter actin cytoskeleton dynamics. Inhibition of ROCK may lead to compensatory mechanisms that enhance FMNL1 activity in actin polymerization. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 hydrochloride is an inhibitor of myosin light chain kinase (MLCK). By inhibiting MLCK, ML-7 can indirectly affect actin dynamics, potentially enhancing FMNL1 activity. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
(S)-(-)-Blebbistatin inhibits myosin II activity, altering actin-myosin interactions. This could lead to increased FMNL1 activity in actin nucleation and polymerization. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin, an inhibitor of the N-WASP, can shift the balance of actin dynamics, potentially increasing FMNL1’s role in actin polymerization and cytoskeletal rearrangements. | ||||||